A New Murine Model of Osteoblastic/Osteolytic Lesions from Human Androgen-Resistant Prostate Cancer

Effects of Bone-Targeted Agents on Cancer Progression and Mortality

(2012) R. Coleman et al.   JNCI-Journal of the National Cancer Institute

Role of the endothelin axis and its antagonists in the treatment of cancer

(2011) A Bagnato et al.   BRITISH JOURNAL OF PHARMACOLOGY

Dual Function of ERR  in Breast Cancer and Bone Metastasis Formation: Implication of VEGF and Osteoprotegerin

(2011) A. Fradet et al.   CANCER RESEARCH

Molecular Alterations during Progression of Prostate Cancer to Androgen Independence

(2011) P. Saraon et al.   CLINICAL CHEMISTRY

Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis

(2011) Naoto Kamiya et al.   International Journal of Clinical Oncology

Abnormal Expression of the ERG Transcription Factor in Prostate Cancer Cells Activates Osteopontin

(2011) S. Flajollet et al.   MOLECULAR CANCER RESEARCH

The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis

(2011) Chiara Secondini et al.   PLoS One

Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer

(2010) Anne Chauchereau et al.   EXPERIMENTAL CELL RESEARCH

Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms

(2008) J. Dai et al.   CANCER RESEARCH

Histopathological Assessment of Prostate Cancer Bone Osteoblastic Metastases

(2008) Martine P. Roudier et al.   JOURNAL OF UROLOGY

Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro

(2007) Edith Bonnelye et al.   BONE

Establishment of an Osteocyte-like Cell Line, MLO-Y4

(2006) Yoichi Kato et al.   JOURNAL OF BONE AND MINERAL RESEARCH